Spacer Spacer Spacer Spacer
Spacer February 2008 Spacer Spacer
Spacer Spacer Spacer
Spacer
Corner Consultant's catch-up Corner
Spacer
Our regular update from one of the regional Implementation Consultant’s.

This month Gill Mathews tells us what she's been up to in the North East.

Greetings again from the frozen North - where the weather has been only one of the challenges facing the Implementation Consultants team during January!

Arrow Read more

Corner Shared learning update Corner
Spacer
Take a look at the latest submissions on our shared learning database.

Spacer
Corner NICE telephone numbers have changed Corner
Spacer
Update your records with the new NICE telephone numbers!

NICE reception 0845 003 7780
NICE enquiries 0845 003 7781
NICE press office 0845 003 7782
NICE publications 0845 003 7783

The NICE Manchester office has also moved
:

Level 1A, City Tower, Piccadilly Plaza
Manchester
M1 4BD
Spacer
Spacer
Corner Revised costing tools for two technology appraisals Corner
Spacer Spacer Spacer

Primary feature 1 - January 2008

Primary feature 2 - January 2008

Spacer
Two costing tools have been revised following feedback from the manufacturer. Revised tools were uploaded to the website on 6 February 2008.

The costing statement accompanying "Infliximab for the treatment of psoriasis" (technology appraisal 134) has been amended to correct the dosing schedule for infliximab.
Spacer Spacer Spacer
Spacer Spacer
Latest implementation tools
Dots
Spacer
Mesothelioma - pemetrexed disodium Psoriasis - infliximab

Physical activity and environment Arteriovenous extracorporeal membrane carbon dioxide removal (AV -ECCO2R)

Spacer Spacer Spacer
Corner Planning ahead for key new medicines and NICE guidance 2008/2009 Corner
Spacer Spacer Spacer
Into practice 0208 - secondary image Spacer

Key topics to inform budget setting and service impact planning

The National Prescribing Centre (NPC) has produced a key document, Planning Ahead, designed to help NHS organisations to develop appropriate plans for managing those new medicines where the clinical and/or resource impact may be sufficiently high to require a local impact assessment and plan of introduction.

Spacer Spacer Spacer
Spacer Spacer
Dots Dots
Recommendation reminders Coming up next month
Dots Dots
Reminders on recommendations from existing NICE guidance that identify ineffective practice Spacer

Spacer
Spacer

Spacer
Spacer
Spacer
Join the External Reference Group and play an active role in shaping tools for implementing NICE guidance. Use your expertise and experience to improve their development